文献速递眼底病与葡萄膜炎

转甲状腺素蛋白通过VEGFA/PI3K/AKT通路调控糖尿病视网膜病变

Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

该研究在高糖处理的视网膜微血管内皮细胞和链脲佐菌素诱导的糖尿病小鼠模型中,探讨转甲状腺素蛋白(TTR)是否通过VEGFA/PI3K/AKT通路影响糖尿病视网膜病变(DR)。结果显示TTR可逆转高糖引起的细胞增殖、迁移和血管生成增加及凋亡减少,并抑制VEGFA、PI3K p-p85和p-AKT水平升高;体内实验进一步证实TTR可减轻糖尿病小鼠DR的发生。

要点

  • TTR可逆转高糖诱导的人视网膜微血管内皮细胞增殖、迁移和血管生成增加及凋亡减少。
  • TTR抑制高糖升高的VEGFA、PI3K p-p85和p-AKT水平,VEGFA可中和TTR的细胞功能。
  • 糖尿病小鼠模型中进一步证实TTR可减轻DR的发生。

核心结论

  • TTR通过分子调控VEGFA/PI3K/AKT轴显著抑制DR的进展。

研究设计与样本

  • 体外采用高糖(25 mM)处理人视网膜微血管内皮细胞(hRMECs),体内采用C57BL/6J小鼠腹腔注射STZ(50 mg/kg)构建DR模型。

主要发现

  • 高糖引起hRMECs增殖、迁移和血管生成增加及凋亡减少,TTR可显著逆转这些变化。
  • TTR显著抑制高糖升高的VEGFA、PI3K p-p85和p-AKT水平。
  • 抑制TTR进一步加重高糖诱导的hRMECs效应,抑制VEGFA可逆转高糖诱导的hRMECs效应。
  • VEGFA可中和TTR对高糖触发hRMECs增殖、凋亡、迁移和血管生成的作用。
  • 体内实验进一步证实TTR可减轻糖尿病小鼠模型中DR的发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Transthyretin (TTR) plays a regulatory role in a variety of diabetes-related diseases. The objective of this work was to probe whether TTR affects diabetic retinopathy (DR) through the VEGFA/PI3K/AKT pathway. METHODS: High glucose (HG, 25 mM) was used to treat human retinal microvascular endothelial cells (hRMECs) and C57BL/6J mice were intraperitoneally injected with STZ (50 mg/kg) to construct a DR model. In vitro, the effect of TTR on DR was evaluated by measuring hRMEC proliferation, migration, and angiogenesis. The changes in retinal tissue were observed by hematoxylin and eosin staining in vivo. ELISA, immunohistochemistry, and immunofluorescence staining were used to measure VEGFA or CD31 levels. The levels of all proteins were evaluated through Western blot. RESULTS: The increase of proliferation, migration, and angiogenesis and decrease of apoptosis in hRMECs caused by HG were notably reversed by TTR. TTR greatly impeded HG-raised VEGFA, PI3K p-p85, and p-AKT in hRMECs. Inhibition of TTR further exacerbated the effect of HG-induced hRMECs. Inhibition of VEGFA reversed the effect of HG-induced hRMECs. VEGFA neutralized the function of TTR on cell proliferation, apoptosis, migration, and angiogenesis in HG-triggered hRMECs. It was further confirmed in vivo that TTR can alleviate the occurrence of DR in diabetic mice models. CONCLUSIONS: TTR significantly restrained the progression of DR via molecular modulation of the VEGFA/PI3K/AKT axis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Liu L, Gao Y, Yao S, et al. Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway. Invest Ophthalmol Vis Sci. 2024. PMID: 38289614. doi:10.1167/iovs.65.1.45

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。